Skip to main content
. 2019 Oct 21;25(39):5973–5990. doi: 10.3748/wjg.v25.i39.5973

Figure 6.

Figure 6

Hsa-miR-6845-5p and hsa-miR-4455 have negative effects on gastric cancer. A: Luciferase reporter assay verifying hsa-miR-6845-5p and hsa-miR-4455 as direct targets of hsa-miR-6845-5p and hsa-miR-4455; B: Determination of the effects of hsa-miR-6845-5p-mimic and hsa-miR-4455-mimic on cell viability in HGC-27 cells; C: Evaluation of the influence of hsa-miR-6845-5p-mimic and hsa-miR-4455-mimic on HGC-27 cell apoptosis; D: Evaluation of the effect of hsa-miR-6845-5p-mimic and hsa-miR-4455-mimic on invasion of HGC-27 cells. Data are reported as the mean ± SD. aP < 0.05, bP < 0.01, and eP < 0.001 for between-group comparisons. NC: Negative control.